Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PET/CT-Derived Hepatopulmonary Shunt Fraction Following Yttrium-90 Radioembolization

NCT02119065 is registered in ClinicalTrials.gov with University of Cincinnati as lead sponsor.

NCT NCT02119065
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02119065 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PET/CT-Derived Hepatopulmonary Shunt Fraction Following Yttrium-90 Radioembolization
Lead sponsor
University of Cincinnati
Phase
Observational
Overall status
Active, not recruiting
Start date
January 30, 2014
Completion date
December 31, 2026
Enrollment
6 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

advanced adult primary liver cancer, liver metastases, localized unresectable adult primary liver cancer, recurrent adult primary liver cancer